Literature DB >> 20605084

Stroke in women.

Sylvia Wassertheil-Smoller1.   

Abstract

AIMS: The aim of this article is to provide an overview of stroke in women and describe modifiable and non-modifiable risk factors for stroke. DATA SYNTHESIS: Data supporting this article come from the National Center for Health Statistics, from American Heart Association publications, and from some of the large, multicenter trials and observational studies that inform guidelines for prevention of stroke. These data indicate that stroke is the third leading cause of death in women, that risk for stroke rises rapidly with age, and that the strongest risk factors for stroke are high blood pressure and atrial fibrillation, as well as diabetes and smoking. Risk rises rapidly when two or more risk factors are present. Hormone therapy in postmenopausal women increases risk of ischemic, but not hemorrhagic stroke, by 40-50%. Biomarkers of inflammation are associated with stroke risk. Other risk factors include certain lipids, physical inactivity, and low potassium diets. Although there has been improvement in the past decade, control of hypertension is inadequate in older women and many strokes could be prevented by better treatment of hypertension.
CONCLUSION: Death and disability from stroke can be reduced with modification, treatment, and better control of risk factors like hypertension, diabetes and atrial fibrillation. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605084      PMCID: PMC3993990          DOI: 10.1016/j.numecd.2010.02.017

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  45 in total

1.  Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Authors:  Margaret C Fang; Daniel E Singer; Yuchiao Chang; Elaine M Hylek; Lori E Henault; Nancy G Jensvold; Alan S Go
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

Review 2.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

Authors:  F Turnbull; B Neal; T Ninomiya; C Algert; H Arima; F Barzi; C Bulpitt; J Chalmers; R Fagard; A Gleason; S Heritier; N Li; V Perkovic; M Woodward; S MacMahon
Journal:  BMJ       Date:  2008-05-14

3.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J DeGraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Circulation       Date:  2006-06-20       Impact factor: 29.690

Review 4.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.

Authors:  Abel Romero-Corral; Victor M Montori; Virend K Somers; Josef Korinek; Randal J Thomas; Thomas G Allison; Farouk Mookadam; Francisco Lopez-Jimenez
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

5.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

6.  Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Christie M Ballantyne; Ron C Hoogeveen; Heejung Bang; Josef Coresh; Aaron R Folsom; Lloyd E Chambless; Merle Myerson; Kenneth K Wu; A Richey Sharrett; Eric Boerwinkle
Journal:  Arch Intern Med       Date:  2005-11-28

7.  Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Robert C Kaplan; Aileen P McGinn; Alison E Baird; Susan L Hendrix; Charles Kooperberg; John Lynch; Daniel M Rosenbaum; Karen C Johnson; Howard D Strickler; Sylvia Wassertheil-Smoller
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Nov-Dec       Impact factor: 2.136

8.  Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.

Authors:  Margaret C Fang; Alan S Go; Yuchiao Chang; Leila Borowsky; Niela K Pomernacki; Daniel E Singer
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

9.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

10.  Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.

Authors:  Sylvia Wassertheil-Smoller; Charles Kooperberg; Aileen P McGinn; Robert C Kaplan; Judith Hsia; Susan L Hendrix; JoAnn E Manson; Jeffrey S Berger; Lewis H Kuller; Matthew A Allison; Alison E Baird
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

View more
  4 in total

Review 1.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

2.  Increased risk of stroke in oral contraceptive users carried replicated genetic variants: a population-based case-control study in China.

Authors:  Chun Wang; Ying Li; Huiqiao Li; Tao Sun; Guangfu Jin; Zhiming Sun; Jian Zhou; Lei Ba; Zhizheng Huang; Jianling Bai
Journal:  Hum Genet       Date:  2012-04-04       Impact factor: 4.132

3.  On the Basis of Sex.

Authors:  Bharti Manwani; Louise D McCullough
Journal:  Stroke       Date:  2019-08-15       Impact factor: 7.914

4.  Prestroke factors associated with poststroke mortality and recovery in older women in the Women's Health Initiative.

Authors:  Christina L Bell; Andrea LaCroix; Kamal Masaki; Erinn M Hade; Todd Manini; W Jerry Mysiw; Jess David Curb; Sylvia Wassertheil-Smoller
Journal:  J Am Geriatr Soc       Date:  2013-07-19       Impact factor: 5.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.